Introduction: Peritonitis is a severe complication of peritoneal dialysis (PD) due to associated morbidity and mortality. Although Bacillus cereus is mostly considered as a contaminant, its role as a causative agent in a few cases of PD peritonitis has been documented. Peritonitis due to B. cereus has been associated with high rates of catheter removal and resistance to beta-lactam antibiotics.
Introduction
Peritoneal dialysis (PD) is one of the main treatment modalities for patients with end-stage renal disease. Despite a series of technological innovations and improvements that have reduced overall infection rates, peritonitis prevalence ranges from 7.5 % to 40 % (Davenport, 2009 ). The spectrum of associated bacteria involves coagulasenegative staphylococci followed by Staphylococcus aureus, streptococci, enterococci, other Gram-positive organisms, Pseudomonas aeruginosa and other Gram negative bacteria, as well as fungi (Davenport, 2009; Nikitidou et al., 2012) .
Bacillus cereus is a common cause of food poisoning; however, it has only occasionally been reported as the etiologic agent of other human infections, including peritonitis. A case of relapsing peritonitis caused by B. cereus in a patient on PD is described and a review of previously reported cases is presented.
Case report
A 69-year-old man with end-stage renal disease on continuous ambulatory PD for 3 years was admitted with an 8-hour history of abdominal pain and fever of 38.5 u C. The patient did not have any recent history of peritonitis or other infections. He did not complain of other gastrointestinal symptoms except abdominal pain and denied eating contaminated rice or food in bad condition. He lived in a rural area and did not adhere strictly to infection prevention recommendations. On admission, the peritoneal effluent was cloudy (white blood cell count 2375 ml
21
, polymorphonuclear neutrophil cells 94 %), while Gram staining revealed the presence of large straight (Li et al., 2010) . Cultures in bottles were detected as positive (BacT/ALERT System, bioMérieux) and yielded Gram-positive bacilli with oval, centrally situated spores, which did not distort the bacillary form. Phenotypic identification as B. cereus was performed by BBL GP cards (bionumber 1315000165, Becton Dickinson Diagnostics), observation of irregular opaque colonies with rough matted surface surrounded by betahaemolysis on blood agar plates, and a positive motility test. MICs of antimicrobials were determined by a gradient method (Etest, bioMérieux) Identification to species level was confirmed by performing PCR using two pairs of universal primers for the 16S rRNA gene. The first pair consisted of the forward primer 16SrRNA1: 59-TGCCAGCAGCCGCGGTAATAC-39 and the reverse primer 16SrRNA2: 59-CGCTCGTTGCGG-GACTTAACC-39, amplifying a 594 bp fragment at positions 10 129-10 722. The second pair of primers were forward 16SrRNA3: 59-AGAGTTTGATCATGGCTCAG-39 and reverse 16SrRNA4: 59-GGYTACCTTGTTACGACTT-39, amplifying a 413 bp fragment at positions 11 021-10 609 (Gatselis et al., 2006) . Sequencing of the amplified products using the ABI PRISM 310 apparatus and comparison with existing universal microbial gene sequencing data (http://blast.ncbi.nlm.nih.gov/Blast.cgi) showed 100 % homology with the B. cereus 16S rRNA gene of strain FT9 (accession number CP008712.1), verifying the initial phenotypic identification.
In accordance to the susceptibility test, the antibiotic regimen was modified with replacement of ceftazidime by tobramycin (LD: 16 mg, MD: 8 mg per 2 l exchange) and treatment continued for a total of 14 days. Three days after the initiation of antibiotics, the patient's clinical condition improved, peritoneal cell count decreased (35 ml 21 ), cultures became sterile and the patient was discharged from hospital after 15 days of antibiotic treatment. 
Discussion
For patients on PD, peritonitis is the most common cause of transition to haemodialysis, accounting for a significant morbidity and mortality ranging from 3.5 to 10 % (Odudu & Wilkie, 2011) . In addition, peritonitis episodes have been implicated with loss of residual renal function, ultrafiltration failure and increased risk of encapsulating peritoneal sclerosis (Odudu & Wilkie, 2011) . In many cases, despite the use of an appropriate antibiotic regimen, peritonitis relapses and catheter removal is often necessitated (Davenport, 2009 ). An important aspect in relapsing peritonitis is biofilm formation on PD catheters, as in our case (Nessim et al., 2012) .
As a cause of PD-associated peritonitis, B. cereus has been recognized in seven previously reported cases accounting for eight patients, seven adults and one paediatric (Biasoli et al., 1984; Al-Wali et al., 1990; Al Hilali et al., 1997; Balakrishnan et al., 1997; Pinedo et al., 2002; Monteverde et al., 2006; Ruiz et al., 2006) . The present case constitutes the ninth one, worldwide, and the first described in Greece. A review of cases published so far is shown in Table 1 . In five cases patients underwent relapsing infections despite appropriate antibiotic treatment (Biasoli et al., 1984; Pinedo et al., 2002; Monteverde et al., 2006; Ruiz et al., 2006) . In all but one case involving relapsing infections, the catheter was removed (Biasoli et al., 1984; Pinedo et al., 2002; Ruiz et al., 2006) . According to ISPD guidelines, the focus should be on the preservation of the peritoneum rather than on saving the peritoneal catheter, whereas, the catheter should be removed in the case of relapsing peritonitis, refractory peritonitis, fungal peritonitis and refractory catheter infections (Li et al., 2010) . The present case fulfils both criteria of relapsing as well as refractory A. Spiliopoulou and others peritonitis since in relapse, the effluent failed to clear after five days of appropriate antibiotic coverage (Li et al., 2010) .
In general, most B. cereus isolates were resistant to betalactams (Turnbull et al., 2004; Luna et al., 2007; Uchino et al., 2012) and trimethoprim (Turnbull et al., 2004) and susceptible to ciprofloxacin, gentamicin and vancomycin (Turnbull et al., 2004; Luna et al., 2007; Uchino et al., 2012) . The spectrum of effective antimicrobials includes fluoroquinolones, rifampicin, daptomycin, linezolid, and tigecycline (Luna et al., 2007) . Susceptibility to erythromycin (Turnbull et al., 2004; Luna et al., 2007) , clindamycin (Luna et al., 2007; Uchino et al., 2012) and tetracycline (Turnbull et al., 2004; Luna et al., 2007) varies, whereas, resistance to carbapenems has been described in bacteraemic cases and environmental isolates (Luna et al., 2007; Savini et al., 2009; Uchino et al., 2012) . In the present case, the bacterium was resistant to the combination of cephalosporins initially administered as empiric therapy. As recommended, once culture and susceptibility results are available, antibiotic therapy must be adjusted (Li et al., 2010) , and tobramycin was added in place of ceftazidime. By the patient's improvement and effluent clearance, therapy continued for 2 weeks, as recommended for coagulase-negative staphylococcal and streptococcal peritonitis (Li et al., 2010) . At the relapse, taking into account susceptibilities of the previously isolated pathogen and ensuring Gram-positive and Gram-negative coverage (Li et al., 2010) , an alternative antibiotic combination consisting of IP vancomycin and intravenous ciprofloxacin was chosen. This combination has also been proposed in a recent study, as first line antibiotic therapy (Goffin et al., 2004) . The selected antibiotics failed to eradicate infection and catheter removal was necessitated. In the reported cases shown in Table 1 , B. cereus peritonitis was cleared and the catheter was preserved in four cases. IP/ intravenous (IV) vancomycin plus IP aminoglycoside (netilmicin or gentamicin) for three or 4 weeks was used in two cases (Balakrishnan et al., 1997; Al Hilali et al., 1997) , teicoplanin for 3 weeks was used in a third case (AlWali et al., 1990) , whereas, IP cefalotin and IP ceftazidime plus oral ciprofloxacin for 3 weeks was administered in the fourth case (Monteverde et al., 2006) . One of the aforementioned combinations, IP vancomycin plus IP gentamicin, administered for 2 weeks, has led to relapse in another case (Pinedo et al., 2002) . Although several antibiotic regimens have been tried with rather inadequate results, catheter removal led to resolution of the infection in all cases.
Although B. cereus peritonitis in patients on PD is very rare, when isolated, it should not be considered as a contaminant. Clinicians and clinical microbiologists must both give serious consideration to the significance of B. cereus isolation and design the best strategy, including an appropriate antibiotic regimen and whenever needed, catheter removal.
